RELMADA THERAPEUTICS, INC. (RLMD)
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
AUTOMATIC DATA PROCESSING INC (ADP)
ADP to Announce Fourth Quarter Fiscal 2026 Financial Results on July 29, 2026
ISOENERGY LTD. (ISOU)
IsoEnergy Provides Update on Wildfire Activity Near Larocque East Project, Athabasca Basin
AIAI HOLDINGS CORP (AIAI)
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
COEPTIS THERAPEUTICS HOLDINGS, INC. (ZSQR)
Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®
AGIOS PHARMACEUTICALS, INC. (AGIO)
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
BIOCRYST PHARMACEUTICALS INC (BCRX)
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
DIANTHUS THERAPEUTICS, INC. /DE/ (DNTH)
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
VENU HOLDING CORP (VENU)
VENU Joins Russell 3000 and Russell 2000 Indexes
KIRBY CORP (KEX)
Kirby Corporation Announces Date for 2026 Second Quarter Earnings Release and Earnings Webcast